China Robotic Surgery Services Market Analysis Report [2022-30]

China Robotic Surgery Services Market Analysis

$ 3999

The China Robotic Surgery Service market size was valued at $345 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 20.8% % from 2022 to 2030 and will reach $1564 Mn in 2030. The robotic surgery service market will grow due to increasing demand for minimally invasive procedures, advancements in technology, and growing prosperity in the country. The market is segmented by product and service type, application type, and end user. Some of the major players are Lingraphica (CHN), Shuanglin Group (CHN), Mirobot (CHN), and others

ID: IN10CNHS017 CATEGORY: Healthcare Services GEOGRAPHY: China AUTHOR: Chandani Patel

Buy Now

China Robotic Surgery Service Market Executive Summary

The China Robotic Surgery Service market size was valued at $345 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 20.8% % from 2022 to 2030 and will reach $1564 Mn in 2030. Healthcare spending in China has been growing rapidly in recent years, driven by a rapidly aging population, increasing prosperity, and a growing demand for healthcare services. According to data from the World Bank, healthcare spending in China reached 7.3% of the country's Gross Domestic Product (GDP) in 2020.

The Chinese government has made significant investments in the country's healthcare system in recent years, with a focus on improving access to care and modernizing the system. This has included building new hospitals and clinics, increasing funding for healthcare services, and expanding insurance coverage. In addition to government spending, private spending on healthcare has also been increasing in China. This is due in part to the growth of the middle class and increasing awareness of the importance of healthcare, as well as the growing availability of private insurance and other forms of private funding for healthcare services.

Robotic surgery services in China have been growing in recent years, it is a relatively new and emerging field in the country. China's healthcare industry has been rapidly modernizing in recent years, and the government has been investing in the development and implementation of advanced medical technologies, including surgical robots. There are now several Chinese companies that manufacture and distribute surgical robots, and there are a growing number of hospitals and clinics that offer robotic surgery services.

In the coming years, it is expected that the use of surgical robots will continue to grow in China as the government continues to invest in the development of the healthcare sector and as more hospitals adopt these technologies.

china robotic surgeries service market analysis

Market Dynamics

Market Growth Drivers

The market for robotic surgery services in China is growing rapidly, driven by increasing demand for minimally invasive procedures, advancements in technology, and growing prosperity in the country.

The growth of the market for surgical robots in China is being driven by several factors, including:

Increasing demand for minimally invasive procedures: As awareness of the benefits of minimally invasive surgery grows, so does the demand for these types of procedures. This is driving the growth of the market for surgical robots in China.
Advances in technology: As surgical robots become more advanced, their applications are expanding, making them a more viable option for a wider range of procedures.
Growing prosperity: As the Chinese economy continues to grow and the middle class expands, more people are able to afford the high cost of robotic surgery services.

Market Restraints

Despite this growth, there are still several challenges facing the market for surgical robots in China, including a shortage of trained healthcare professionals, high costs, and limited access to care in rural areas.

Additionally, there is still a need for further research and development to improve the technology and make it more widely accessible.

Competitive Landscape

Key Players

Lingraphica (CHN)
Shuanglin Group (CHN)
Mirobot (CHN)
3D Medical (CHN)
Fosun Pharma (CHN)
Medtronic
THINK Surgical, Inc.
Zimmer Biomet

Notable Deals

In 2020, Fosun Pharma acquired a controlling stake in Intuitive Surgical, a leading provider of robotic surgical systems. This acquisition marked a significant move by Fosun Pharma into the market for surgical robots, and it is expected to help the company establish a strong position in this growing market.

In 2019, Mirobot merged with Beijing Bluefocus, a leading digital marketing company in China. The merger is expected to help Mirobot expand its reach and capabilities in the market for surgical robots, as well as provide access to new technologies and expertise.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

In China, the regulation of robotic surgical services is overseen by several government bodies, including the National Medical Products Administration (NMPA) and the China Food and Drug Administration (CFDA). These agencies are responsible for regulating the safety and efficacy of medical devices, including surgical robots.

Reimbursement for robotic surgical services in China is determined by the National Healthcare Security Administration (NHSA), which sets guidelines and policies for medical reimbursement across the country. The NHSA determines which procedures are eligible for reimbursement, as well as the amount of reimbursement that will be provided.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Robotic Surgery Services Market Segmentation

By Product and Services (Revenue, USD Billion):

The surgical robotics market volume data has been covered for all the major surgical robotics systems. In terms of value, the surgical systems market is anticipated to expand at a CAGR of 11.22% from 2018 to 2025.

Instruments and Accessories
Robotic Systems
Services

By Application (Revenue, USD Billion):

Gynecology accounted for the largest market share in 2017 and is anticipated to expand at a CAGR of 7.0% from 2018 to 2025. This is explained by the rising prevalence of gynecological complications in women worldwide and the ongoing development of robotic technologies.

General Surgery
Gynecological Surgery
Urological Surgery
Neurosurgery
Orthopedic Surgery
Other Applications

By End User (Revenue, USD Billion):

The hospitals' segment had the largest market value in 2017 and experienced a CAGR of 13.20% from 2018 to 2025. However, during the projected period of 2018–2025, the ambulatory surgical center's income is predicted to rise at the highest CAGR of 18.20%.

Hospitals
Ambulatory Surgery Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.